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We describe the case of a 22-year-old black female with type 1 diabetes mellitus diagnosed when she was
12 years old. She first presented (March 1994) with pustules and ulcerations on the upper and lower limbs,
trunk and scalp at the age 17. The diagnosis of pyoderma gangrenosum was made. Since presentation,
changes in liver function were detected and subsequent study led to the diagnosis of sclerosing cholan-
gitis. The diagnosis of ulcerative colitis was made after colonoscopy. Partial response was obtained with
minocycline and clofazimine, but treatment with 5-aminosalicylic acid achieved no improvement of the























Pyoderma gangrenosum is an inflammatory, ulcerative skin
disease of unknown aetiology. It is frequently associated with
systemic diseases, such as intestinal inflammatory disorders,
rheumatoid arthritis, chronic active hepatitis, diabetes mellitus and
malignant haematological diseases. Clinically, the ulcerations are
characterized by peripheral growth and detached, undermined,




We describe the case of a patient in whom pyoderma gan-
grenosum was associated with sclerosing cholangitis, ulcerative




A black female student, born in March 1977, residing in
Portugal since 1990, had no known inherited or familial
diseases. At the age of 12 years, she was diagnosed as having type
1 diabetes mellitus. Three years later, she was hospitalized
for the first time for diabetic ketoacidosis, with altered





transpeptidase, 710 U/L; oxaloacetic transaminase, 355 U/L;
and pyruvic transaminase, 255 U/L.
In 1994, the patient presented to the Department of Derma-
tology (Hospital de Curry Cabral, Lisbon, Portugal) with
ulcerations of the abdominal wall and inner right malleolus,
and multiple papulo-pustules on the scalp. The lesions arose as
papulo-pustules developing into extensive ulcerations with
raised and partially detached borders, occupying almost the
whole circumference of the lower third of the leg (fig. 1). Oral
treatment with amoxycillin, clavulanic acid, minocycline and
clofazimine achieved improvement of the lesions. The dia-
gnostic hypothesis of pyoderma gangrenosum was made.
The patient was readmitted for many times for ulcerations of
the leg and dorsum of the foot similar to those already described
coinciding with aggravation of the liver function test. In 1995
she was admitted to the Department of Endocrinology with
diabetic decompensation due to bloody diarrhoea. Since then,
there have been episodes of diarrhoea, rectorrhagia and abdominal
pain.
Of the complementary tests performed, total colonoscopy
with exploration of the terminal ileum showed ulcerative colitis and
the endoscopic retrograde cholangiopancreatography sclerosing
cholangitis. The liver biopsy indicated chronic cholangitis.
Therapy was initiated with oral 5-aminosalicylic acid (5-ASA),
3 g per day plus 250 mg at night in suppository form.
 

















The patient maintained extensive ulcerations on both legs
and aggravation of the hepatic function. Liver transplant was
performed in March 1997 (histology revealed stage I sclerosing
cholangitis). After transplantation, she was medicated with
azathioprine, cyclosporin and prednisolone and, since Feb-
ruary 1999, with cyclosporin 375 mg/day, mycophenolate
mofetil 3 g/day and 5-ASA 3 g/day.
The ulcerations healed with formation of hyperpigmented,
atrophic, parchment-like scars, and there was no further mani-




The association of pyoderma gangrenosum with ulcerative
colitis and sclerosing cholangitis, particularly the former,




 In most cases,





Sclerosing cholangitis is a rare disease characterized by
inflammation and partial or total sclerosis of the extrahepatic
and intrahepatic biliary tree, leading to secondary biliary















 In a study on the prevalence of









As for pyoderma gangrenosum, there are very few reports of
association with diabetes mellitus, and always in elderly patients





In our patient, unusually, pyoderma gangrenosum, in the
form of extensive and incapacitant ulcerations and the hepatic
changes secondary to sclerosing cholangitis, preceded the ulcer-
ative colitis symptoms, which were rapidly controlled with 5-
ASA therapy. The recourse to liver transplantation as the only
possible treatment for the sclerosing cholangitis resulted in
complete remission of the skin lesions. The efficacy of oral cor-
ticoid therapy, of the immunosuppressors, namely azathioprine
and cyclosporin and, more recently, mycophenolate mofetil,





 Likewise, the control of associated systemic
diseases has achieved good results with the cutaneous lesions,




. In a case of triple association of
ulcerative colitis, sclerosing cholangitis and pyoderma gan-
grenosum, significant improvement was obtained with colec-




Given the fact that our patient’s liver transplantation was
followed, as is usual in such cases, by therapy with azathioprine,
cyclosporin and prednisolone and, subsequently, with cyclo-
sporin and mycophenolate mofetil, which had not been admin-
istered previously, we wonder what played the key part in the
clinical improvement: the transplantation or the therapy that
followed it? We do not exclude the hypothesis that it may have
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fig. 1 Ulceration on the lower third of the right leg.
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